Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis.

作者: Robert Beaumont Wilson

DOI: 10.1515/PP-2018-0103

关键词:

摘要: Peritoneal response to various kinds of injury involves loss peritoneal mesothelial cells (PMC), danger signalling, epithelial-mesenchymal transition and mesothelial-mesenchymal (MMT). Encapsulating sclerosis (EPS), endometriosis (EM) metastasis (PM) are all characterized by hypoxia formation a vascularized connective tissue stroma mediated vascular endothelial growth factor (VEGF). Transforming factor-β1 (TGF-β1) is constitutively expressed the PMC plays major role in maintenance transformed, inflammatory micro-environment PM, but also EPS EM. Persistently high levels TGF-β1 or stimulation cytokines (interleukin-6 (IL-6)) induce MMT, adhesion fibrosis. enhances inducible factor-1α expression, which drives cell growth, extracellular matrix production migration. Disruption glycocalyx exposure basement membrane release low molecular weight hyaluronan, initiates cascade pro-inflammatory mediators, including (TNF-α, IL-1, IL-6, prostaglandins), factors (TGF-α, TGF-β, platelet-derived factor, VEGF, epidermal factor) fibrin/coagulation (thrombin, Tissue plasminogen activator inhibitor [PAI]-1/2). Chronic inflammation cellular transformation damage-associated patterns, pattern recognition receptors, AGE-RAGE, lactate, cytokines, reactive oxygen species, increased glycolysis, metabolomic reprogramming cancer-associated fibroblasts. The pathogenesis EPS, EM PM shows similarities stromal recruitment wound healing.

参考文章(147)
Jung S. Byun, Kevin Gardner, Wounds That Will Not Heal The American Journal of Pathology. ,vol. 182, pp. 1055- 1064 ,(2013) , 10.1016/J.AJPATH.2013.01.009
Tomoko Saito, Junji Kurashige, Sho Nambara, Hisateru Komatsu, Hidenari Hirata, Masami Ueda, Shotaro Sakimura, Ryutaro Uchi, Yuki Takano, Yoshiaki Shinden, Tomohiro Iguchi, Hidetoshi Eguchi, Shogo Ehata, Kazunari Murakami, Keishi Sugimachi, Koshi Mimori, A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Annals of Surgical Oncology. ,vol. 22, pp. 915- 922 ,(2015) , 10.1245/S10434-015-4554-8
Hideki Kawanishi, Surgical and Medical Treatments of Encapsulation Peritoneal Sclerosis Contributions To Nephrology. ,vol. 177, pp. 38- 47 ,(2012) , 10.1159/000336934
Katharina Proestling, Peter Birner, Susanne Gamperl, Nadine Nirtl, Erika Marton, Gülen Yerlikaya, Rene Wenzl, Berthold Streubel, Heinrich Husslein, Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis Reproductive Biology and Endocrinology. ,vol. 13, pp. 75- 75 ,(2015) , 10.1186/S12958-015-0063-7
Suniti Misra, Vincent C. Hascall, Roger R. Markwald, Shibnath Ghatak, Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer Frontiers in Immunology. ,vol. 6, pp. 201- 201 ,(2015) , 10.3389/FIMMU.2015.00201
Guo Qiang Chen, Shao Ming Shen, Xu Yun Zhao, Wei Liu, Targeted genes and interacting proteins of hypoxia inducible factor-1 International journal of biochemistry and molecular biology. ,vol. 3, pp. 165- 178 ,(2012)
R. Govinden, K.D. Bhoola, Genealogy, expression, and cellular function of transforming growth factor-β Pharmacology & Therapeutics. ,vol. 98, pp. 257- 265 ,(2003) , 10.1016/S0163-7258(03)00035-4
Jean-Charles Neel, Laure Humbert, Jean-Jacques Lebrun, The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis International Scholarly Research Notices. ,vol. 2012, pp. 381428- 381428 ,(2012) , 10.5402/2012/381428
Alferso C. Abrahams, Sayed M. Habib, Amélie Dendooven, Bruce L. Riser, Jan Willem van der Veer, Raechel J. Toorop, Michiel G. H. Betjes, Marianne C. Verhaar, Christopher J. E. Watson, Tri Q. Nguyen, Walther H. Boer, Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor. PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0112050